296 related articles for article (PubMed ID: 32597888)
1. [Efficacy of micronized purified flavonoid fraction in treatment of chronic venous oedema].
Bogachev VI; Boldin BV; Turkin PI; Samenkov AI
Angiol Sosud Khir; 2020; 26(2):86-94. PubMed ID: 32597888
[TBL] [Abstract][Full Text] [Related]
2. [Comparative efficacy of various methods of treatment of chronic venous oedema in real clinical practice].
Bogachev VI; Boldin BV; Turkin PI; Samenkov AI;
Angiol Sosud Khir; 2021; 27(3):77-83. PubMed ID: 34528591
[TBL] [Abstract][Full Text] [Related]
3. VEIN STEP: A Prospective, Observational, International Study to Assess Effectiveness of Conservative Treatments in Chronic Venous Disease.
Mezalek ZT; Feodor T; Chernukha L; Chen Z; Rueda A; Sánchez IE; Ochoa AJG; Chirol J; Blanc-Guillemaud V; Lohier-Durel C; Ulloa JH
Adv Ther; 2023 Nov; 40(11):5016-5036. PubMed ID: 37728696
[TBL] [Abstract][Full Text] [Related]
4. [Perioperative administration of micronized purified flavonoid fraction in endovascular treatment of varicose disease].
Bogachev VI; Boldin BV; Turkin PI
Angiol Sosud Khir; 2019; 25(2):88-95. PubMed ID: 31149994
[TBL] [Abstract][Full Text] [Related]
5. Chronic venous insufficiency: worldwide results of the RELIEF study. Reflux assEssment and quaLity of lIfe improvEment with micronized Flavonoids.
Jantet G
Angiology; 2002; 53(3):245-56. PubMed ID: 12025911
[TBL] [Abstract][Full Text] [Related]
6. [Pharmacological correction of total venous reflux in patients with varicose veins].
Khorev NG; Kuznetsova DV
Angiol Sosud Khir; 2021; 27(1):84-89. PubMed ID: 33825733
[TBL] [Abstract][Full Text] [Related]
7. Recommendations for the medical management of chronic venous disease: The role of Micronized Purified Flavanoid Fraction (MPFF).
Bush R; Comerota A; Meissner M; Raffetto JD; Hahn SR; Freeman K
Phlebology; 2017 Apr; 32(1_suppl):3-19. PubMed ID: 28211296
[TBL] [Abstract][Full Text] [Related]
8. Administration of Micronized Purified Flavonoid Fraction During Sclerotherapy of Reticular Veins and Telangiectasias: Results of the National, Multicenter, Observational Program VEIN ACT PROLONGED-C1.
Bogachev VY; Boldin BV; Turkin PY
Adv Ther; 2018 Jul; 35(7):1001-1008. PubMed ID: 29949043
[TBL] [Abstract][Full Text] [Related]
9. [Ultrasound elastography in assessing efficacy of treatment for lower limb varicose veins with a phlebotrophic drug containing a micronized purified flavonoid fraction].
Zubarev AR; Krivosheeva NV; Demidova aK; Rychkova IV
Angiol Sosud Khir; 2014; 20(2):90-6. PubMed ID: 24961330
[TBL] [Abstract][Full Text] [Related]
10. RELIEF study: first consolidated European data. Reflux assEssment and quaLity of lIfe improvement with micronized Flavonoids.
Jantet G
Angiology; 2000 Jan; 51(1):31-7. PubMed ID: 10667641
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the effects of micronized purified flavonoid fraction versus placebo on symptoms and quality of life in patients suffering from chronic venous disease: from a prospective randomized trial.
Rabe E; Agus GB; Roztocil K
Int Angiol; 2015 Oct; 34(5):428-36. PubMed ID: 25972136
[TBL] [Abstract][Full Text] [Related]
12. Micronized purified flavonoid fraction-based conservative treatment of chronic venous disease in a real-world setting.
Bogachev V; Boldin B; Turkin P; Samenkov A; Dzhenina O
Future Cardiol; 2022 Sep; 18(10):777-785. PubMed ID: 36004765
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of micronized purified flavonoid fraction (Daflon®) on improving individual symptoms, signs and quality of life in patients with chronic venous disease: a systematic review and meta-analysis of randomized double-blind placebo-controlled trials.
Kakkos SK; Nicolaides AN
Int Angiol; 2018 Apr; 37(2):143-154. PubMed ID: 29385792
[TBL] [Abstract][Full Text] [Related]
14. Clinical efficacy of once-daily micronized purified flavonoid fraction 1000 mg tablet in patients with symptomatic chronic venous disease.
Kirienko A; Radak D; Maggioli A
Curr Med Res Opin; 2019 Mar; 35(3):553-557. PubMed ID: 29992831
[TBL] [Abstract][Full Text] [Related]
15. [Efficacy of sulodexide in treatment of chronic venous insufficiency. Results of the ACCORD trial].
Bogachev VI; Golovanova OV; Malysheva IN
Angiol Sosud Khir; 2017; 23(3):83-88. PubMed ID: 28902818
[TBL] [Abstract][Full Text] [Related]
16. [Additional possibilities in conservative treatment of patients with post-thrombotic disease of lower limbs].
Kuznetsov MR; Bogachev VI; Sapelkin SV; Papysheva OV; Neskhodimov LA; Khotinskiĭ AA; Mazitova MI
Angiol Sosud Khir; 2020; 26(1):31-36. PubMed ID: 32240133
[TBL] [Abstract][Full Text] [Related]
17. [Placebo controlled efficacy of class 1 elastic stockings in chronic venous insufficiency of the lower limbs].
Vayssairat M; Ziani E; Houot B
J Mal Vasc; 2000 Oct; 25(4):256-62. PubMed ID: 11060420
[TBL] [Abstract][Full Text] [Related]
18. Daflon 500 mg: symptoms and edema clinical update.
Ramelet AA
Angiology; 2005; 56 Suppl 1():S25-32. PubMed ID: 16193223
[TBL] [Abstract][Full Text] [Related]
19. Clinical Efficacy of Conservative Treatment with Micronized Purified Flavonoid Fraction in Female Patients with Pelvic Congestion Syndrome.
Akhmetzianov RV; Bredikhin RA
Pain Ther; 2021 Dec; 10(2):1567-1578. PubMed ID: 34537951
[TBL] [Abstract][Full Text] [Related]
20. Clinical efficacy of micronized purified flavonoid fraction (MPFF) in edema.
Olszewski W
Angiology; 2000 Jan; 51(1):25-9. PubMed ID: 10667640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
